Fingerprint
Dive into the research topics of 'A phase II study (ARCHER 1042) to evaluate prophylactic treatment of dacomitinib-induced dermatologic and gastrointestinal adverse events in advanced non-small-cell lung cancer'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically